Details of the Drug
General Information of Drug (ID: DMALRCH)
| Drug Name |
Phaclofen
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Phaclofen; 114012-12-3; [3-amino-2-(4-chlorophenyl)propyl]phosphonic acid; (3-Amino-2-(4-chlorophenyl)propyl)phosphonic acid; Phosphonic acid, (3-amino-2-(4-chlorophenyl)propyl)-; 3-Amino-2-(4-chlorophenyl)propylphosphonic acid; 3-Amino-2-(4-chlorophenyl) propylphosphonic acid; Phosphonic acid,P-[3-amino-2-(4-chlorophenyl)propyl]-; SR-01000075640; Phaclofen, solid; beta-(4-Chlorophenyl)-3-aminopropylphosphonic acid; ACMC-20djlx; 108351-35-5; AC1Q3NDJ; AC1L1BWO; Biomol-NT_000256; Lopac0_000967; SCHEMBL339995; GTPL1091
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 249.63 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -2.4 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References


